Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Nancy A. Melville

    News

    MM:New Tool Gauges Post–CAR T Relapse Risk

    Author:
    Nancy A. Melville
    Publish date: February 29, 2024

    Key disease, treatment, and inflammation risk factors predict patients at a higher risk of relapse.

    • Read More

    News

    Selenium Supplementation Shows Thyroid Benefits

    Author:
    Nancy A. Melville
    Publish date: February 20, 2024

    Systematic review suggests selenium supplements may help patients with Hashimoto thyroiditis.

    • Read More

    News

    CAR T-Cell: Do Benefits Still Outweigh Risks?

    Author:
    Nancy A. Melville
    Publish date: February 14, 2024

    “Cautious reassurance” urged, as early reports suggest that the risks of secondary malignancies are similar to those of other cancer treatments....

    • Read More

    News

    Testosterone Replacement Shows No Benefit in Diabetes Prevention

    Author:
    Nancy A. Melville
    Publish date: February 9, 2024

    The study showed that the only major indication for testosterone replacement therapy is to treat symptoms of hypogonadism.

    • Read More

    News

    SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes

    Author:
    Nancy A. Melville
    Publish date: February 7, 2024

    Patients with T2DM who are treated with SGLT2 inhibitors have reduced risk of kidney stones, according to study.

    • Read More

    News

    Stockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North America

    Author:
    Nancy A. Melville
    Publish date: January 30, 2024

    The Stockholm3 blood test, using a multiplex algorithm, shows benefits over PSA in a diverse, multi-ethnic cohort beyond a Swedish population...

    • Read More

    News

    ctDNA Clearance Improves Prediction of Relapse Risk in Urothelial Cancer

    Author:
    Nancy A. Melville
    Publish date: January 29, 2024

    The combination of ctDNA with other biomarkers shows further benefits in predicting treatment response.

    • Read More

    News

    T-ALL: Cranial Radiotherapy Yields Little Benefit

    Author:
    Nancy A. Melville
    Publish date: January 23, 2024

    Comparisons of T-ALL cohorts show similar outcomes, with or without radiotherapy.

    • Read More

    News

    Are Post-Meal Insulin Surges Beneficial?

    Author:
    Nancy A. Melville
    Publish date: January 5, 2024

    Rapid surges in insulin following a meal are associated with favorable long-term cardiometabolic benefits, including improvements in beta cell...

    • Read More

    News

    ALL: Asparaginase Tx Boosts Survival in AYA Patients

    Author:
    Nancy A. Melville
    Publish date: December 22, 2023

    Intensive C10403 regimen showed “very encouraging” improvements in event-free, overall survival in teenagers and young adults with ALL.

    • Read More

    News

    Children who are overweight at risk for chronic kidney disease

    Author:
    Nancy A. Melville
    Publish date: December 13, 2023

    “Given the increasing obesity rates among adolescents, our findings are a harbinger of the potentially preventable increasing burden of CKD and...

    • Read More

    News

    Anti-Rheumatic Drugs Linked to Reduced Thyroid Disease Incidence

    Author:
    Nancy A. Melville
    Publish date: December 12, 2023

    In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs. the general population, with the...

    • Read More

    News

    Myeloma: Isatuximab Four-Drug Regimen Boosts MRD Negativity

    Author:
    Nancy A. Melville
    Publish date: December 11, 2023

    Quadruplet regimen with anti-CD38 drug isatuximab improved MRD negativity vs. the standard triplet regimen in newly diagnosed myeloma patients.

    • Read More

    News

    Telemedicine in diabetes care associated with worse outcomes

    Author:
    Nancy A. Melville
    Publish date: December 11, 2023

    Patients receiving telemedicine-only care had no significant changes or improvements in adjusted A1c whereas those receiving in-person care had a...

    • Read More

    News

    Relapsed DLBCL: With Complete Interim Response, SCT Outperforms CAR T

    Author:
    Nancy A. Melville
    Publish date: December 11, 2023

    Awaiting CAR T therapy, patients with complete response to interim chemo show better outcomes with subsequent autologous transplantation, compared...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery